Multiple myeloma drug candidates are crucial in advancing treatment options. AbbVie seeks FDA approval for its latest candidate.
Rhapsido FDA approval brings new hope for patients with innovative treatment options.
Bile duct cancer drug approval brings hope for patients. What does it mean?